Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany June 17.

Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as being particularly good for the company. Last year, Ferring had record sales of ...

Ferring achieved record sales driven by Reproductive Medicine combined with the emergence of Adstiladrin For more information, please contact Carine Julen Senior Manager, Corporate Communications ...

Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an immune checkpoint inhibitor in high-risk Bacillus Calmette-Guérin (BCG ...

Ferring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin ...

Ferring Pharmaceuticals has reached a new milestone on its quest to satisfy current and future demand for its bladder cancer gene therapy Adstiladrin.

This milestone represents significant progress in Ferring’s manufacturing capabilities to meet anticipated growth in demand for Adstiladrin® (nadofaragene firadenovec-vncg), a gene therapy ...

The program is supported through Ferring’s Fertility Out Loud platform and is designed to support both male and female partners through their fertility journey.

Infertility isn’t an easy subject to talk about — and Ferring Pharmaceuticals knows it. Challenges related to family planning have been associated with social stigmatization, particularly for female ...

Collaboration leverages the proven development and commercial capability of Ferring with PharmaBiome’s compelling technology to research, develop and manufacture novel donor-independent ...

Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are announcing a research and development collaboration to drive forward new microbiome-based biotherapeutics in the ...

Ferring Pharmaceuticals has informed the state that it will lay off 55 employees from its Roseville manufacturing, research and development plant. The plant at 2660 Patton Road in Roseville is ...